Coaching & mentoring leaders to develop people, build high-performing teams & cultivate inclusive culture for organisational performanceDriving excellence through consulting in Biotechnology product or service development

Developing future leadersBuilding strong teamsLeading through changeAdvancing platform technologies

Linda's research expertise is in the field of protein expression and purification technology. She has researched and developed technologies to effectively produce valued protein-based products. Her most significant contributions have led to advances in both knowledge and technology development in two areas:1. Protein production technology for effective generation of novel synthetic proteins essential for discovery and translational research, aim at accelerating the research of others.2. Vaccine technology that addresses the speed, cost, and efficacy of vaccine manufacturing, aim at improving vaccine accessibility in developing countries.Current research focussing on integrated bimolecular and bioprocess engineering- Virus-like particle vaccine platform technology- Integrated continuous biomanufacturing- Protein-based bioproducts

Enable people to excel in research and develop impactful and meaningful careersDevelop and implement University-wide researcher development initiatives for academic and professional research staff:- 70:20:10 model on learning and development- Vitae Researcher Development Framework (RDF) and RDF Planner- Culture, Employment and Development in Academic Research Survey (CEDARS)- Mentoring best practice (formal, informal, cross-sector, individual and cohort)- Targeted programs to overcome barriers for attraction, retention and progression of academic women- Research career advising

Gender Steering Committee 2019-2022Science in Australia Gender Equity (SAGE) Sell-assessment Team for Athena SWAN 2016-2018Chair, Research Institute Gender Equity Commission 2016-2018

Linda’s vision and leadership has established UQ Protein Expression Facility as a leading protein production facility in Australia. Together with her high performing team, she has worked on hundreds of proteins for diverse applications in the areas of structural biology and chemistry, drug screening and discovery, vaccine development and delivery, protein therapeutics, functionalised material, biomedical imaging and agricultural science. She has also developed training programs within the Facility to upskill research students and staff. The Protein Expression Facility has a global reputation for excellence and was awarded the Deputy Vice-Chancellor Research and Innovation Award for Impact (2020) and Team Excellence in 2018, 2016 UQ Award for Excellence in Service and the Chancellor’s Award for Team Excellence in 2013. These awards are recognitions and testaments to Linda's exemplary leadership, rightfully awarded the UQ Award for Excellence in Leadership 2021.Linda has a broad impact on research through the establishment and progressive expansion of the Protein Expression Facility. Using her extensive experience on recombinant protein production, she has established a robust platform that supports parallel protein production in a comprehensive range of expression hosts (E. coli, yeast, baculovirus/insect cell and mammalian cell). She works closely with researchers to tailor expression and purification strategies designed to produce target proteins for their intended use. These partnerships have enabled cutting-edge research for more than 500 researchers in over 100 academic and industry organisations, globally and nationally. Her accomplishment has led to invitations for her to design and facilitate workshops at international higher education and research institutions. She also provides advice to others on establishing protein facilities.

Biotherapeutic and vaccine developmentProtein design and bioproductionPlatform facility establishment and sustainabilityWorkshop design, delivery and facilitation

Conference Co-chair, Vaccine Technology IX 2024Conference Co-chair, Vaccine Technology VIII 2022Conference Co-chair, Vaccine Technology Virtual 2020Organising Committee and Session Chair, Vaccine Technology VII 2018 Organising Committee and Session Chair, Vaccine Technology VI 2016Session Chair, Vaccine Technology V 2014

Associate Editor 2019 - 2021Special Issues Guest Editor 2015, 2016, 2017, 2018

Bioprocess engineering the industrial-scale production of baculovirus biopesticide